T. Rowe Price Associates’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.9M | Sell |
|
|||||
2025
Q1 | $2.1M | Sell |
|
|||||
2024
Q4 | $4.89M | Sell |
|
|||||
2024
Q3 | $5.3M | Sell |
|
|||||
2024
Q2 | $7.83M | Sell |
|
|||||
2024
Q1 | $9.7M | Buy |
|
|||||
2023
Q4 | $8.48M | Sell |
|
|||||
2023
Q3 | $9.1M | Sell |
|
|||||
2023
Q2 | $14.1M | Buy |
|
|||||
2023
Q1 | $6.95M | Buy |
|
|||||
2022
Q4 | $4.86M | Sell |
|
|||||
2022
Q3 | $5M | Buy |
|
|||||
2022
Q2 | $4.89M | Buy |
|
|||||
2022
Q1 | $344K | Sell |
|
|||||
2021
Q4 | $246K | Buy |
|
|||||
2021
Q3 | $235K | Buy |
|
|||||
2021
Q2 | $262K | Sell |
|
|||||
2021
Q1 | $308K | Buy |
|
|||||
2019
Q1 | – | Sell |
|
|||||
2018
Q4 | $1.23M | Sell |
|
|||||
2018
Q3 | $4.59M | Buy |
|
|||||
2018
Q2 | $642K | Buy |
|
|||||
2017
Q3 | – | Sell |
|
|||||
2017
Q2 | $1.35M | Buy |
|
|||||
2017
Q1 | $785K | Sell |
|
|||||
2016
Q4 | $1.31M | Buy |
|